Lgm Digital Ad 970x90

Debiopharm Seeks to Expand at Swiss Site
By

Debiopharm Group,  a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland). The company reports that it is interested in building through acquisitions

“We want to be the bridge between development and industrialization” says Cédric Sager, chief executive officer of Debiopharm Research & Manufacturing S.A. “and supply Swiss-made products manufactured using state-of-the-art technology. Hard-to-make drugs, highly complex formulated drugs, biologic niche products, premium diagnostics and medical devices are on our wish-list.”

Thierry Mauvernay, delegate of the board of Debiopharm Group, explains that “we have invested heavily during the last years to automate our site in Martigny as much as possible. Thanks to our efforts, we have increased our productivity. Our wish now is to acquire new industrial opportunities to strengthen our activity in Valais and support our development”.

Source: Debiopharm

Leave a Reply

Your email address will not be published.

Altasciences Billboard Dcat